1. Home
  2. NSYS vs NRSN Comparison

NSYS vs NRSN Comparison

Compare NSYS & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nortech Systems Incorporated

NSYS

Nortech Systems Incorporated

HOLD

Current Price

$13.45

Market Cap

25.6M

Sector

Technology

ML Signal

HOLD

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.72

Market Cap

24.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSYS
NRSN
Founded
1981
2017
Country
United States
Israel
Employees
N/A
15
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.6M
24.4M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
NSYS
NRSN
Price
$13.45
$0.72
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
18.7K
183.4K
Earning Date
05-13-2026
03-20-2026
Dividend Yield
N/A
N/A
EPS Growth
80.85
N/A
EPS
N/A
N/A
Revenue
$14,371,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$583.67
P/E Ratio
N/A
N/A
Revenue Growth
7.01
N/A
52 Week Low
$6.50
$0.63
52 Week High
$13.36
$2.60

Technical Indicators

Market Signals
Indicator
NSYS
NRSN
Relative Strength Index (RSI) 81.26 40.24
Support Level $8.40 $0.66
Resistance Level N/A $1.30
Average True Range (ATR) 0.58 0.07
MACD 0.28 0.00
Stochastic Oscillator 93.67 43.43

Price Performance

Historical Comparison
NSYS
NRSN

About NSYS Nortech Systems Incorporated

Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: